Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
FRA:YMP3
Delisted

Symphony Holdings Limited Stock Price (Quote)

Frankfurt Stock Exchange
Open Broker Account
0.0890€
+0 (+0%)
At Close: Aug 17, 2022
Forecast Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days 0.0890€ 0.0890€ Wednesday, 17th Aug 2022 YMP3.F stock ended at 0.0890€. During the day the stock fluctuated 0% from a day low at 0.0890€ to a day high of 0.0890€.
90 days 0.0890€ 0.0890€
52 weeks 0.0890€ 0.0905€

Historical Symphony Holdings Limited prices

Date Open High Low Close Volume
Oct 28, 2019 0.106€ 0.106€ 0.106€ 0.106€ 22 500
Oct 25, 2019 0.103€ 0.103€ 0.103€ 0.103€ 22 500
Oct 24, 2019 0.102€ 0.102€ 0.102€ 0.102€ 22 500
Oct 23, 2019 0.101€ 0.101€ 0.101€ 0.101€ 22 500
Oct 22, 2019 0.0980€ 0.0980€ 0.0980€ 0.0980€ 22 500
Oct 21, 2019 0.0955€ 0.0955€ 0.0955€ 0.0955€ 22 500
Oct 18, 2019 0.0950€ 0.0950€ 0.0950€ 0.0950€ 22 500
Oct 17, 2019 0.0945€ 0.0930€ 0.0930€ 0.0955€ 22 500
Oct 16, 2019 0.0930€ 0.0930€ 0.0930€ 0.0945€ 22 500
Oct 15, 2019 0.0930€ 0.0930€ 0.0930€ 0.0930€ 22 500
Oct 14, 2019 0.0935€ 0.0935€ 0.0935€ 0.0935€ 22 500
Oct 11, 2019 0.0935€ 0.0935€ 0.0935€ 0.0935€ 22 500
Oct 10, 2019 0.0935€ 0.0935€ 0.0935€ 0.0935€ 22 500
Oct 09, 2019 0.0940€ 0.0940€ 0.0940€ 0.0940€ 22 500
Oct 08, 2019 0.0950€ 0.0950€ 0.0950€ 0.0950€ 22 500
Oct 07, 2019 0.0950€ 0.0950€ 0.0950€ 0.0950€ 22 500
Oct 04, 2019 0.0950€ 0.0950€ 0.0950€ 0.0950€ 22 500
Oct 02, 2019 0.0945€ 0.0945€ 0.0940€ 0.0940€ 22 500
Oct 01, 2019 0.0960€ 0.0960€ 0.0960€ 0.0960€ 22 500
Sep 30, 2019 0.0940€ 0.0955€ 0.0940€ 0.0955€ 22 500
Sep 27, 2019 0.0930€ 0.0930€ 0.0930€ 0.0930€ 22 500
Sep 26, 2019 0.0974€ 0.0974€ 0.0974€ 0.0974€ 22 500
Sep 25, 2019 0.0946€ 0.0946€ 0.0946€ 0.0946€ 22 500
Sep 24, 2019 0.0912€ 0.0912€ 0.0912€ 0.0912€ 22 500
Sep 23, 2019 0.0887€ 0.0887€ 0.0887€ 0.0887€ 22 500
Click to get the best stock tips daily for free!

About Symphony Holdings Limited

Symphony Holdings Limited Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,... YMP3.F Profile

Golden Star

Ticker Date Change Price
PAG May 07 1.87% $153.22
WMT May 06 0.95% $59.87
UNP May 06 3.09% $239.21
JPM May 06 2.86% $192.00
ASH May 03 2.10% $95.85
INVH May 03 1.72% $34.39
INGR May 03 4.72% $114.56
VCSH May 03 0.0260% $76.93
BNDX May 03 0.205% $48.68
BBCA May 03 1.93% $65.44
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT